C1 inhibitor functional activities in hereditary angioedema plasma of patients under therapy with attenuated...

Area of Science:

• Immunology
• Endocrinology
• Genetics

Background:

• Hereditary angioedema (HAE) is a rare genetic disorder characterized by recurrent swelling attacks.
• The complement system, particularly complement component C4 and C1 inhibitor, plays a crucial role in HAE pathogenesis.
• Attenuated androgens are used to manage HAE, but their precise effects on the complement system require further elucidation.

Purpose of the Study:

• To investigate the impact of danazol or stanozolol therapy on complement component C4 levels.
• To assess the effects of these therapies on C1 inhibitor concentration and functional activity in HAE patients.

Main Methods:

• The study involved 6 patients with the common form of hereditary angioedema.
• Blood samples were analyzed to measure complement component C4 levels.
• C1 inhibitor concentrations and functional activities were quantified before and during therapy with danazol or stanozolol.

Main Results:

• Mean C4 concentration remained within the normal range during therapy.
• Therapy with attenuated androgens led to a subnormal mean C1 inhibitor concentration.
• Despite reduced concentration, the functional activity of C1 inhibitor was found to be almost normal.

Conclusions:

• Danazol and stanozolol therapy appear to normalize C1 inhibitor function in HAE patients, despite reducing its overall concentration.
• These findings highlight a complex regulatory mechanism of the complement system by attenuated androgens.
• Further research is warranted to fully understand the long-term implications of these hormonal effects on HAE management.